Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7049622
Reference Type
Journal Article
Title
Pressure support ventilation-pro decreases propofol consumption and improves postoperative oxygenation index compared with pressure-controlled ventilation in children undergoing ambulatory surgery: a randomized controlled trial
Author(s)
Moharana, S; Jain, D; Bhardwaj, N; Gandhi, K; Yaddanapudi, S; Parikh, B; ,
Year
2020
Is Peer Reviewed?
1
Journal
Canadian Journal of Anesthesia
ISSN:
0832-610X
EISSN:
1496-8975
Publisher
SPRINGER
Location
NEW YORK
Volume
67
Issue
4
Page Numbers
445-451
Language
English
PMID
31898776
DOI
10.1007/s12630-019-01556-9
Web of Science Id
WOS:000505338300001
Abstract
Purpose The PSVPro mode is increasingly being used for surgeries under laryngeal mask airway owing to improved ventilator-patient synchrony and decreased work of breathing. We hypothesized that PSVPro ventilation mode would reduce consumption of anesthetic agents compared with pressure control ventilation (PCV). Methods Seventy children between three and eight years of age undergoing elective lower abdominal and urological surgery were randomized into PCV group (n = 35) or PSVPro group (n = 35). General anesthesia was induced with sevoflurane and a Proseal LMA (TM) was inserted. Anesthesia was maintained with propofol infusion to maintain the entropy values between 40 and 60. In the PCV mode, the inspiratory pressure was adjusted to obtain an expiratory tidal volume of 8 mL center dot kg(-1) and a respiratory rate of 12-20/min. In the PSVPRO group, the flow trigger was set at 0.4 L center dot min(-1) and pressure support was adjusted to obtain expiratory tidal volume of 8 mL center dot kg(-1). Consumption of anesthetic agent was recorded as the primary outcome. Emergence time and discharge time were recorded as secondary outcomes. Results The PSVPro group showed significant reduction in propofol consumption compared with the PCV group (mean difference, 33.3 mu g(-1)center dot kg(-1)center dot min(-1); 95% confidence interval [CI], 24.2 to 42.2). There was decrease in the emergence time in the PSVPro group compared with the PCV group (mean difference, 3.5 min; 95% CI, 2.8 to 4.2) and in time to achieve modified Aldrete score > 9 (mean difference, 3.6 min; 95% CI, 1.9 to 5.2). Conclusion The PSVPro mode decreases propofol consumption and emergence time, and improves oxygenation index in children undergoing ambulatory surgery.
Tags
•
PFAS 150
Literature Search Update December 2021
PubMed
Missing 2021 searches
Literature Search Update December 2020
PubMed
Literature Search August 2019
PubMed
Not prioritized for screening
1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy)propane
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity